Multidrug-resistant tuberculosis

E-poster session
Chairs: K. Dheda (Cape Town, South Africa), A. Skrahina (Minsk region, Belarus)

Diagnostic utility of Primary  Line Probe Assay in Extrapulmonary Tuberculosis D. Muthreja (Nagpur (Maharashtra), India), R. Swarnakar (Nagpur (Maharashtra), India), A. Sontakke (Nagpur (Maharashtra), India)
Bioresorbable polymer structures - promising carriers for prolonged forms of anti-tuberculosis drugs T. Smirnova (Moscow, Russian Federation), E. Antonov (Moscow, Russian Federation), S. Andreevskaya (Moscow, Russian Federation), S. Bogorodski (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation), V. Popov (Moscow, Russian Federation)
Trends in tuberculosis notification and treatment in Georgia N. Kiria (Tbilisi, Georgia), Z. Avaliani (Tbilisi, Georgia), M. Chincharauli (Tbilisi, Georgia), L. Mikiashvili (Tbilisi, Georgia)
The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence S. Borisov (Moscow, Russian Federation), A. Filippov (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation), T. Ivanushkina (Moscow, Russian Federation), E. Belilovsky (Moscow, Russian Federation)
Time to detection of Mycobacterium tuberculosis on liquid media as reflection of initial bacterial load - population data from 6 sample regions of the Russian Federation G. Kaminskiy (Moscow, Russian Federation), A. Panova (Moscow, Russian Federation), E. Veselova (Moscow, Russian Federation), I. Sherstnev (Nijnij Novgorod, Russian Federation), I. Osintseva (Kemerovow, Russian Federation), V. Testov (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil T. Malaquias (Rio De Janeiro (RJ), Brazil), A. Santos (Rio De Janeiro (RJ), Brazil), E. Costa (Rio De Janeiro (RJ), Brazil), F. Mello (Rio De Janeiro (RJ), Brazil), A. Kritski (Rio De Janeiro (RJ), Brazil)
Mutation analysis and treatment outcomes of Isoniazid monoresistant tuberculosis R. Gurram (Visakhapatnam, India), V. Kaminedi (Visakhapatnam, India), P. Kotti (Visakhapatnam, India), Y. Chintha (Visakhapatnam, India)
Pulmonary surfactant: a Trojan Horse to deliver anti-TB drugs A. Hidalgo (Saarbrücken, Germany), J. Perez-Gil (Madrid, Spain), C. Lehr (Saarbrücken, Germany)
Household catastrophic expenditure for tuberculosis care among adults = 18 years in Pakistan: Incidence, its determinants and policy implications S. Razzaq (Lahore, Pakistan), S. Naeem (Karachi, Pakistan), Z. Fatmi (Karachi, Pakistan)
Assessment of the dynamics of focal changes after the intensive phase of treatment in patients with sensitive and resistant pulmonary tuberculosis M. Gumeniuk (Kyiv, Ukraine), M. Lynnyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), V. Ignatieva (Kyiv, Ukraine), O. Denysov (Kyiv, Ukraine)
Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis T. Morozova (Saratov, Russian Federation), O. Otpuschenniykova (Saratov, Russian Federation)
An outbreak of extensively drug-resistant tuberculosis among a Portuguese family R. Pereira De Matos Cordeiro (Torres Vedras, Portugal), A. Nunes (Torres Vedras, Portugal), C. Rolo (Torres Vedras, Portugal), D. Duarte (Torres Vedras, Portugal), N. André (Torres Vedras, Portugal), R. Macedo (Lisboa, Portugal), A. Domingos (Torres Vedras, Portugal)
TREATMENT OF MDR-TB PATIENTS WITH DELETION POLYMORPHISM OF XENOBIOTICS DETOXICATION SYSTEM GENES OF GLUTATHIONE-S-TRANSFERASE I. Semianiv (Chernivtsi, Ukraine), L. Todoriko (Chernivtsi, Ukraine), M. Semianiv (Chernivtsi, Ukraine)
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients D. Vakhrusheva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), K. Belousova (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), T. Umpeleva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), N. Eremeeva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation)
Tuberculosis in children exposed to MTB with different drug resistance patterns M. Lozovskaya (St. Petersburg, Russian Federation), A. Kurova (St. Petersburg, Russian Federation), N. Nikiforenko (St. Petersburg, Russian Federation), E. Vasilieva (St. Petersburg, Russian Federation), I. Yarovaya (St. Petersburg, Russian Federation), L. Klochkova (St. Petersburg, Russian Federation)
Demographic characteristics of drug-resistant tuberculosis in the Russian Federation S. Sterlikov (Moscow, Russian Federation), L. Rusakova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), Y. Mikhaylova (Moscow, Russian Federation)
Treatment outcome in patients with MDR-TB treated with bedaquiline containing regimens, Republic of Moldova D. Chesov (Chisinau, Republic of Moldova), J. Heyckendorf (Borstel, Germany), M. Reiman (Borstel, Germany), S. Alexandru (Chisinau, Republic of Moldova), A. Donica (Chisinau, Republic of Moldova), E. Chesov (Chisinau, Republic of Moldova), V. Crudu (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova), C. Lange (Borstel, Germany)
Two year experience with the GeneXpert NAAT system in the romanian M. tuberculosis NRC in Bucharest M. Adriana (Bucuresti, Romania), A. Muntean (Bucuresti, Romania), M. Popa (Bucuresti, Romania)
A UK cost comparison of amikacin therapy with bedaquiline, for drug resistant tuberculosis K. Manalan (London, United Kingdom), N. Green (London, United Kingdom), A. Arnold (London, United Kingdom), G. Cooke (London, United Kingdom), M. Dedicoat (Birmingham, United Kingdom), M. Lipman (London, United Kingdom), T. Harrison (London, United Kingdom), O. Kon (London, United Kingdom)
Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India J. Tornheim (Baltimore, United States of America), E. Intini (Rome, Italy), A. Gupta (Baltimore, United States of America), Z. Udwadia (Mumbai, India)